Patient-Derived Organoid Biobanks for Translational Research and Precision Medicine: Challenges and Future Perspectives
- PMID: 40863456
- PMCID: PMC12387782
- DOI: 10.3390/jpm15080394
Patient-Derived Organoid Biobanks for Translational Research and Precision Medicine: Challenges and Future Perspectives
Abstract
Over the past decade, patient-derived organoids (PDOs) have emerged as powerful in vitro models that closely recapitulate the histological, genetic, and functional features of their parental primary tissues, representing a ground-breaking tool for cancer research and precision medicine. This advancement has led to the development of living PDO biobanks, collections of organoids derived from a wide range of tumor types and patient populations, which serve as essential platforms for drug screening, biomarker discovery, and functional genomics. The classification and global distribution of these biobanks reflect a growing international effort to standardize protocols and broaden accessibility, supporting both basic and translational research. While their relevance to personalized medicine is increasingly recognized, the establishment and maintenance of PDO biobanks remain technically demanding, particularly in terms of optimizing long-term culture conditions, preserving sample viability, and mimicking the tumor microenvironment. In this context, this review provides an overview of the classification and worldwide distribution of tumor and paired healthy tissue-specific PDO biobanks, explores their translational applications, highlights recent advances in culture systems and media formulations, and discusses current challenges and future perspectives for their integration into clinical practice.
Keywords: living biobanks; organoids; personalized medicine; translational research.
Conflict of interest statement
The authors declare no potential conflicts of interest.
Figures





Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Organoid Models Established from Primary Tumors and Patient-Derived Xenograft Tumors Reflect Platinum Sensitivity of Ovarian Cancer Patients.bioRxiv [Preprint]. 2025 May 2:2024.06.28.601283. doi: 10.1101/2024.06.28.601283. bioRxiv. 2025. PMID: 40654830 Free PMC article. Preprint.
-
Short-Term Memory Impairment.2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
-
Vascularised organoids: Recent advances and applications in cancer research.Clin Transl Med. 2025 Mar;15(3):e70258. doi: 10.1002/ctm2.70258. Clin Transl Med. 2025. PMID: 40045486 Free PMC article.
-
Innovations in cancer treatment: evaluating drug resistance with lab-on-a-chip technologies.Int J Pharm. 2025 Sep 15;682:125936. doi: 10.1016/j.ijpharm.2025.125936. Epub 2025 Jul 5. Int J Pharm. 2025. PMID: 40623610 Review.
References
-
- Sato T., Stange D.E., Ferrante M., Vries R.G.J., Van Es J.H., Van den Brink S., Van Houdt W.J., Pronk A., Van Gorp J., Siersema P.D., et al. Long-Term Expansion of Epithelial Organoids from Human Colon, Adenoma, Adenocarcinoma, and Barrett’s Epithelium. Gastroenterology. 2011;141:1762–1772. doi: 10.1053/j.gastro.2011.07.050. - DOI - PubMed
-
- Bartfeld S., Bayram T., van de Wetering M., Huch M., Begthel H., Kujala P., Vries R., Peters P.J., Clevers H. In Vitro Expansion of Human Gastric Epithelial Stem Cells and Their Responses to Bacterial Infection. Gastroenterology. 2015;148:126–136.e6. doi: 10.1053/j.gastro.2014.09.042. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous